Contribute to creating and developing novel therapeutic strategies for neurodegenerative disease, with an emphasis on CNS drug delivery, oligonucleotide and/or AAV therapeutics.
Base: $126,000.00 - $234,000.00; Bonus/Equity: Performance-based cash incentive and annual equity awards eligibility; Benefits: Comprehensive benefits package including health, life, disability, 401(k), generous time off
Must-have
Nice-to-have
Not specified